A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects
Clinical trial NCT02568306 · COMPLETED
Trial details
- NCT number
- NCT02568306
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-05
- Primary completion
- 2017-02-07
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.